From the Research
Vitamin E is not used for the treatment of Ataxia, as the provided evidence does not support its use for this condition. The question of whether Vitamin E is used for Ataxia can be answered by considering the available evidence, which does not mention Ataxia as an indication for Vitamin E use. Instead, the evidence focuses on the use of Vitamin E in the treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) 1, 2, 3, 4, 5. Key points to consider include:
- The most recent and highest quality study, a 2024 Cochrane review, found that Vitamin E likely reduces serum alanine transaminase (ALT) and aspartate aminotransferase (AST) levels compared with placebo or no intervention in people with NAFLD, but the evidence for its effects on all-cause mortality, liver-related mortality, and serious adverse events is very uncertain 1.
- Other studies have shown that Vitamin E may improve liver function and histologic changes in patients with NAFLD/NASH, but its use as an adjuvant therapy should be decided by a healthcare provider after weighing potential benefits against risks 2, 3, 4, 5.
- The primary approach for managing NAFLD should focus on lifestyle modifications, particularly weight loss through diet and exercise, rather than Vitamin E supplementation.
- There is no evidence to support the use of Vitamin E for the treatment of Ataxia, and therefore it is not recommended for this condition.